Temisis Therapeutics is a therapeutic company focusing on the development of small-molecule assets for the treatment of unmet needs in pathologies possessing an inflammatory component.
Sosei Heptares is a biopharmaceutical company that specializes in drug development.
Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.
Heron Therapeutics is a biotechnology company engaged in drug discovery and development.
Vandœuvre-lès-Nancy, FR HQ
Tokyo, JP HQ
Lund, SE HQ
San Diego, US HQ
Valuation ($)1.8 b
Valuation ($)1.4 b
Valuation ($)132.9 m
Revenue (est.)¥15.6b (FY, 2022)
Revenue (est.)kr956.3m (FY, 2022)
Revenue (est.)$107.7m (FY, 2022)
Cost of goods
Cost of goodsN/A
Cost of goods¥490m (FY, 2022)
Cost of goodskr90.2m (FY, 2022)
Cost of goods$54.9m (FY, 2022)
Gross profit¥15.7b (FY, 2022)
Gross profitkr866.9m (FY, 2022)
Gross profit$52.8m (FY, 2022)
Net income¥1.8b (FY, 2022)
Net incomekr55.6m (FY, 2022)
Net income($182m) (FY, 2022)